Biopharmaceutical Excipients Market Size and Forecast to 2035
Introduction:
The Global Biopharmaceutical Excipients Market is witnessing strong growth, driven by the increasing demand for biologics and biosimilars, rising investments in biopharmaceutical research and development, and growing adoption of advanced drug delivery systems. Biopharmaceutical excipients play a crucial role in improving the stability, efficacy, safety, and shelf life of biologic drugs. Technological advancements in formulation science, expanding biopharmaceutical manufacturing capabilities, and increasing regulatory approvals for biologic therapies are expected to support long-term market growth globally.
Get Free Sample Of This Premium Report:
https://www.decisionsadvisors.com/request-sample/DAR4207
Biopharmaceutical Excipients Market Insights
Based on Deep Market Insights findings, the Global Biopharmaceutical Excipients Market was valued at USD 2.50 Billion in 2024 and is projected to reach USD 4.95 Billion by 2035.
From 2025 to 2035, the market is expected to grow at a CAGR of 6.41%.
Within the Product Type category, Carbohydrates dominated in 2024 in terms of market size contribution.
Over the forecast period, Specialty Excipients and Functional Excipients are forecasted to deliver the fastest growth due to increasing demand for advanced biologic formulations, enhanced drug stability, and improved therapeutic performance.
Other Key Findings
• North America accounted for a significant share of the global Biopharmaceutical Excipients Market in 2024 and remained a major revenue-generating region.
• Europe is expected to emerge as the fastest-growing regional market owing to increasing biopharmaceutical production, expanding biosimilar development activities, and favorable regulatory support.
• Asia-Pacific remained a key regional market supported by growing investments in biotechnology and pharmaceutical manufacturing infrastructure.
• Rising demand for biologics, innovative drug formulations, and advanced excipient technologies continues to support global market growth.
Report Summary
Report Scope
Details
|
Parameter |
Information |
|
Base Year for Study |
2024 |
|
Study Period |
2021–2035 |
|
Historical Period |
2021–2024 |
|
Forecast Period |
2025–2035 |
|
Market Size In 2024 |
USD 2.50 Billion |
|
Market Size In 2035 |
USD 4.95 Billion |
|
Fastest Growing Region |
Europe |
|
Units |
Revenue in USD Billion |
|
CAGR |
6.41% (2025–2035) |
Segmentation Covered
|
Category |
Segments |
|
Product Type |
1. Carbohydrates 2. Polyols 3. Surfactants 4. Polymers 5. Inorganic Salts 6. Others |
|
Functionality |
1. Stabilizers 2. Solubilizers 3. Preservatives 4. Buffering Agents 5. Tonicity Modifiers 6. Others |
|
Formulation Type |
1. Monoclonal Antibodies 2. Vaccines 3. Recombinant Proteins 4. Gene Therapies 5. Others |
|
End User |
1. Biopharmaceutical Companies 2. Contract Manufacturing Organizations (CMOs) 3. Research Institutes |
|
Region |
1. North America 2. Europe 3. Asia-Pacific 4. Latin America 5. Middle East & Africa |
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Drivers, Industry Trends, Technology Advancements, Regulatory Landscape, Supply Chain Analysis, Formulation Development Assessment, and Regional Analysis.
Companies
Ashland Global Holdings Inc., BASF SE, Roquette Frères, Evonik Industries AG, Croda International Plc, DuPont de Nemours, Inc., Colorcon Inc., Associated British Foods plc, Merck KGaA, and Kerry Group plc.
Want detailed insights, forecasts, and competitive analysis?
Check out the full report now:
https://www.decisionsadvisors.com/reports/biopharmaceutical-excipients-market
Connect with us
- USA - +1 303 800 4326
- APAC - +1 303 800 4326
- sales@sphericalinsights.com